Actos is a type-2 diabetes drug manufactured by Takeda Pharmaceuticals. Recent studies indicate that Actos users have a higher than normal chance of developing bladder cancer. There has not yet been any Actos recall in the United States, though it has been pulled from the market in France and Germany after a three-year study showed that diabetics who use Actos have 22% greater risk of bladder cancer, compared to diabetics who do not use Actos.
The relationship between Actos and bladder cancer may be relatively simple to prove, particularly because bladder cancer has so few causes. Bladder cancer may cause symptoms including:
Lawyers are investigating whether the possible dangerous effects of bladder cancer were well-known to Takeda Pharmaceuticals, and whether the company should have warned consumers and doctors earlier. Taking their claims through the federal courts, lawyers convened today in Georgia to ask that the numerous existing and future Actos claims be combined in an MDL (multidistrict litigation), where one judge would oversee and shepherd these cases to conclusion.
Bloomberg Businessweek reports that the drug company may face as many as 10,000 Actos-related lawsuits. The drug’s primary competitor, Avandia (manufactured by GlaxoSmithKline), faced litigation over increased heart attacks, which set the stage for a higher Actos market share.
If you or a loved one has taken Actos and has symptoms of bladder cancer or has been diagnosed with bladder cancer, please call us at 443.850.4426 for a free consultation, or contact us online.